Lobaplatin promotes 125I-induced apoptosis and inhibition of proliferation in hepatocellular carcinoma by upregulating PERK-eIF2α-ATF4-CHOP pathway. The gene discussed is EIF2AK3; the disease is hepatocellular carcinoma.